The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease
Open accessAbstract
Alterations to the gut microbiota have been previously suggested to be tightly linked to chronic systemic inflammation, which is a major contributing factor to complications and disease progression in chronic kidney disease (CKD). Nevertheless, the effect of gut dysbiosis on the pathogenesis and/or production of inflammatory factors in CKD has not been extensively studied to date. In the present study, we conducted 16S ribosomal DNA pyrosequencing using fecal microbiota samples and analyzed the production of serum inflammatory factors in 50 patients with CKD and 22 healthy control (HC) subjects. The results revealed that compared to the HC subjects, patients with CKD exhibited a significant reduction in the richness and structure of their fecal microbiota. At the phylum level, compared to the HC group, patients with CKD also presented reduced abundance of Actinobacteria but increased abundance of Verrucomicrobia. Moreover, the genera Lactobacillus, Clostridium IV, Paraprevotella, Clostridium sensu stricto, Desulfovibrio, and Alloprevotella were enriched in the fecal samples of patients with CKD, while Akkermansia and Parasutterella were enriched in those of the HC subjects. Finally, we analyzed whether these changes to the fecal microbiota correlated with CKD clinical characteristics and/or the production of known inflammatory factors. Altered levels of the microbiota genera Parasutterella, Lactobacillus, Paraprevotella, Clostridium sensu stricto, and Desulfovibrio were shown to be correlated with CKD disease-severity indicators, including the estimated glomerular filtration rate. Most notably, Akkermansia was significantly negatively correlated with the production of interleukin-10. The results of the present study suggest that microbiota dysbiosis may promote chronic systemic inflammation in CKD. Furthermore, they support that modifying the gut microbiota may be a promising potential therapeutic strategy to attenuate the progression of, and/or systemic inflammation in, CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Diet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257
Taxonomy, Physiology, and Natural Products of Actinobacteria
Barka, E. A., Vatsa, P., Sanchez, L., Gaveau-Vaillant, N., Jacquard, C., Klenk, H.-P., Clément, C., Ouhdouch, Y., & van Wezel, G. P. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00019-15 · Cited by 2,188
Chronic kidney disease alters intestinal microbial flora
Vaziri, N. D., Wong, J., Pahl, M., Piceno, Y. M., Yuan, J., DeSantis, T. Z., Ni, Z., Nguyen, T.-H., & Andersen, G. L. (2013) · Kidney International · doi:10.1038/ki.2012.345 · Cited by 1,164
Ottman, N., Reunanen, J., Meijerink, M., Pietilä, T. E., Kainulainen, V., Klievink, J., Huuskonen, L., Aalvink, S., Skurnik, M., Boeren, S., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173004 · Cited by 520
The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease
Anders, H.-J., Andersen, K., & Stecher, B. (2013) · Kidney International · doi:10.1038/ki.2012.440 · Cited by 493
Gryp, T., Vanholder, R., Vaneechoutte, M., & Glorieux, G. (2017) · Toxins · doi:10.3390/toxins9020052 · Cited by 417
NLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Seregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Pudlo, N. A., Mitchell, J., Baxter, N. T., Zhao, L., Schloss, P. D., Martens, E. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.080 · Cited by 386
Hänninen, A., Toivonen, R., Pöysti, S., Belzer, C., Plovier, H., Ouwerkerk, J. P., Emani, R., Cani, P. D., & De Vos, W. M. (2018) · Gut · doi:10.1136/gutjnl-2017-314508 · Cited by 359
Missailidis, C., Hällqvist, J., Qureshi, A. R., Barany, P., Heimbürger, O., Lindholm, B., Stenvinkel, P., & Bergman, P. (2016) · PLOS ONE · doi:10.1371/journal.pone.0141738 · Cited by 338
Action and function of Akkermansia muciniphila in microbiome ecology, health and disease
Ottman, N., Geerlings, S. Y., Aalvink, S., de Vos, W. M., & Belzer, C. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.10.001 · Cited by 289
Parasutterella, in association with irritable bowel syndrome and intestinal chronic inflammation
Chen, Y., Wu, H., Wu, S., Lu, N., Wang, Y., Liu, H., Dong, L., Liu, T., & Shen, X. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14281 · Cited by 284
Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism
Greer, R. L., Dong, X., Moraes, A. C. F., Zielke, R. A., Fernandes, G. R., Peremyslova, E., Vasquez-Perez, S., Schoenborn, A. A., Gomes, E. P., Pereira, A. C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13329 · Cited by 279
Alteration of the gut microbiota in Chinese population with chronic kidney disease
Jiang, S., Xie, S., Lv, D., Wang, P., He, H., Zhang, T., Zhou, Y., Lin, Q., Zhou, H., Jiang, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02989-2 · Cited by 266
Gut microbiome in chronic kidney disease: challenges and opportunities
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J., & Raj, D. (2017) · Translational Research · doi:10.1016/j.trsl.2016.04.007 · Cited by 255
Linking the Microbiota, Chronic Disease, and the Immune System
Hand, T. W., Vujkovic-Cvijin, I., Ridaura, V. K., & Belkaid, Y. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.08.003 · Cited by 247
Protective Effect of Akkermansia muciniphila against Immune-Mediated Liver Injury in a Mouse Model
Wu, W., Lv, L., Shi, D., Ye, J., Fang, D., Guo, F., Li, Y., He, X., & Li, L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01804 · Cited by 246
Alterations of intestinal barrier and microbiota in chronic kidney disease
Sabatino, A., Regolisti, G., Brusasco, I., Cabassi, A., Morabito, S., & Fiaccadori, E. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu287 · Cited by 227
Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease
Sabatino, A., Regolisti, G., Cosola, C., Gesualdo, L., & Fiaccadori, E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0841-z · Cited by 200
Gut microbiome and kidney disease: a bidirectional relationship
Al Khodor, S., & Shatat, I. F. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3392-7 · Cited by 191
Gut Microbial Community Structure and Complications After Kidney Transplantation: A Pilot Study
Lee, J. R., Muthukumar, T., Dadhania, D., Toussaint, N. C., Ling, L., Pamer, E., & Suthanthiran, M. (2014) · Transplantation · doi:10.1097/tp.0000000000000370 · Cited by 190
Ticinesi, A., Milani, C., Guerra, A., Allegri, F., Lauretani, F., Nouvenne, A., Mancabelli, L., Lugli, G. A., Turroni, F., Duranti, S., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315734 · Cited by 185
Rossi, M., Campbell, K. L., Johnson, D. W., Stanton, T., Vesey, D. A., Coombes, J. S., Weston, K. S., Hawley, C. M., McWhinney, B. C., Ungerer, J. P. J., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.04.002 · Cited by 178
The impact of gut microbiota on kidney function and pathogenesis
Mahmoodpoor, F., Rahbar Saadat, Y., Barzegari, A., Ardalan, M., & Zununi Vahed, S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.066 · Cited by 172
Mafra, D., Lobo, J. C., Barros, A. F. H., Koppe, L., Vaziri, N. D., & Fouque, D. P. (2014) · Future Microbiology · doi:10.2217/fmb.13.165 · Cited by 167
The Influence of CKD on Colonic Microbial Metabolism
Poesen, R., Windey, K., Neven, E., Kuypers, D. R. J., Preter, V. D., Augustijns, P., D’Haese, P. C., Evenepoel, P., Verbeke, K., & Meijers, B. K. I. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015030279 · Cited by 133
The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response
Huang, W. G., Zhou, L., Guo, H., Xu, Y., & Xu, Y. (2016) · Metabolism · doi:10.1016/j.metabol.2016.11.006 · Cited by 127
Yoshifuji, A., Wakino, S., Irie, J., Tajima, T., Hasegawa, K., Kanda, T., Tokuyama, H., Hayashi, K., & Itoh, H. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv353 · Cited by 111
Inflammation: A Key Contributor to the Genesis and Progression of Chronic Kidney Disease
Qian, Q. (2017) · Contributions to nephrology · doi:10.1159/000479257 · Cited by 79
Ruiz‐Andrés, O., Sánchez-Niño, M. D., Moreno, J. A., Ruiz‐Ortega, M., Ramos, A. M., Sanz, A. B., & Ortíz, A. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00487.2016 · Cited by 72
The Relationship between IL-10 Levels and Cardiovascular Events in Patients with CKD
Yılmaz, M. İ., Solak, Y., Sağlam, M., Çaycı, T., Açıkel, C., Ünal, H. U., Eyileten, T., Oğuz, Y., Sarı, S., Carrero, J. J., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08660813 · Cited by 65
An update on the role of the inflammasomes in the pathogenesis of kidney diseases
Darisipudi, M. N., & Knauf, F. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3153-z · Cited by 49
Arenas-Padilla, M., Duarte-Gutiérrez, J. L., & Mata‐Haro, V. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.14069 · Cited by 21
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
Self-citationInfluence of Mediterranean Diet on Human Gut Microbiota
Merra, G., Noce, A., Marrone, G., Cintoni, M., Tarsitano, M. G., Capacci, A., & De Lorenzo, A. (2020) · Nutrients · doi:10.3390/nu13010007 · Cited by 417
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Du, Y., He, C., An, Y., Huang, Y., Zhang, H., Fu, W., Wang, M., Shan, Z., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137379 · Cited by 384
Self-citationRETRACTED ARTICLE: Role of the gut microbiome in chronic diseases: a narrative review
Vijay, A., & Valdes, A. M. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00991-6 · Cited by 361
RetractedGut–organ axis: a microbial outreach and networking
Ahlawat, S., Asha, & Sharma, K. K. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13333 · Cited by 361
Metadata
- Authors
- Li, F., Wang, M., Wang, J., Li, R., & Zhang, Y.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2019-06-12
- Volume
- 9
- Pages
- 206-206
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W2951646794
- Cited by
- 288
- References
- 33
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.